Eosinophilic fasciitis is a rare connective tissue disease of unknown etiology. Therapeutic options include high-dose corticosteroids and other immunosuppressive drugs. We present a typical eosinophilic fasciitis case, which did not respond to first-line treatment, but improved remarkably after infliximab administration. This report demonstrates that in case of initial treatment failure, infliximab might be a relatively safe and effective way of eosinophilic fasciitis management.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8892936PMC
http://dx.doi.org/10.1177/23971983211004399DOI Listing

Publication Analysis

Top Keywords

eosinophilic fasciitis
16
refractory eosinophilic
4
fasciitis
4
fasciitis treated
4
treated infliximab
4
infliximab case
4
case report
4
report eosinophilic
4
fasciitis rare
4
rare connective
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!